COMPASS Pathways (CMPS) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET
Updated Oct 15, 2026, 4:00 PM ET
- Closed at $11.62, +3.11% vs the prior close of $11.27.
- Volume 2.80M shares, 1.0x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
CMPS jumps 3.1% to $11.62. Closed at $11.62, +3.11% vs the prior close of $11.27. Day range $11.15–$11.69, opened at $11.25.
CMPS daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 — CMPS jumps 3.1% to $11.62
- Closed at $11.62, +3.11% vs the prior close of $11.27. Day range $11.15–$11.69, opened at $11.25.
- Volume was 2.80M shares, 1.0x its 50-day average of 2.75M.
- Price is -13.0% vs its 50-day average ($13.36) and +14.4% vs its 200-day average ($10.16).
- 52-week range $4.88–$15.87; today's close sits at 61% of that range, 26.8% below the 52-week high.
Oct 14, 2026 — CMPS rises 1.2% to $11.27
- Closed at $11.27, +1.17% vs the prior close of $11.14. Day range $10.97–$11.50, opened at $11.09.
- Volume was 2.53M shares, 0.9x its 50-day average of 2.74M.
- Price is -15.9% vs its 50-day average ($13.40) and +11.2% vs its 200-day average ($10.13).
- 52-week range $4.88–$15.87; today's close sits at 58% of that range, 29.0% below the 52-week high.
Oct 13, 2026 — CMPS slides 3.4% to $11.14, a 1-month low
- Closed at $11.14, -3.38% vs the prior close of $11.53. Day range $11.11–$11.54, opened at $11.54.
- Volume was 1.87M shares, 0.7x its 50-day average of 2.76M.
- Price is -16.9% vs its 50-day average ($13.41) and +10.2% vs its 200-day average ($10.11).
- 52-week range $4.88–$15.87; today's close sits at 57% of that range, 29.8% below the 52-week high.
Oct 12, 2026 — CMPS slides 3.9% to $11.53
- Closed at $11.53, -3.92% vs the prior close of $12.00. Day range $11.53–$12.05, opened at $12.02.
- Volume was 1.96M shares, 0.7x its 50-day average of 2.76M.
- Price is -14.1% vs its 50-day average ($13.42) and +14.3% vs its 200-day average ($10.09).
- 52-week range $4.88–$15.87; today's close sits at 61% of that range, 27.3% below the 52-week high.
Oct 9, 2026 — CMPS jumps 4.6% to $12.00
- Closed at $12.00, +4.62% vs the prior close of $11.47. Day range $11.42–$12.07, opened at $11.69.
- Volume was 2.28M shares, 0.8x its 50-day average of 2.75M.
- Price is -10.5% vs its 50-day average ($13.41) and +19.2% vs its 200-day average ($10.06).
- 52-week range $4.88–$15.87; today's close sits at 65% of that range, 24.4% below the 52-week high.
Oct 8, 2026 — CMPS dips 1.9% to $11.47, a 1-month low
- Closed at $11.47, -1.88% vs the prior close of $11.69. Day range $11.13–$11.79, opened at $11.69.
- Volume was 2.83M shares, 1.0x its 50-day average of 2.75M.
- Price is -14.4% vs its 50-day average ($13.40) and +14.3% vs its 200-day average ($10.04).
- 52-week range $4.88–$15.87; today's close sits at 60% of that range, 27.7% below the 52-week high.
Oct 7, 2026 — CMPS rises 1.1% to $11.69
- Closed at $11.69, +1.12% vs the prior close of $11.56. Day range $11.45–$11.86, opened at $11.50.
- Volume was 1.58M shares, 0.6x its 50-day average of 2.77M — lighter than usual.
- Price is -12.7% vs its 50-day average ($13.39) and +16.8% vs its 200-day average ($10.01).
- 52-week range $4.88–$15.87; today's close sits at 62% of that range, 26.3% below the 52-week high.
Oct 6, 2026 — CMPS dips 0.3% to $11.56, a 1-month low, 6 down days in a row
- Closed at $11.56, -0.34% vs the prior close of $11.60. Day range $11.17–$11.80, opened at $11.72.
- Volume was 2.80M shares, 1.0x its 50-day average of 2.78M.
- Price is -13.6% vs its 50-day average ($13.37) and +15.8% vs its 200-day average ($9.98).
- 52-week range $4.88–$15.87; today's close sits at 61% of that range, 27.2% below the 52-week high.
- That makes 6 straight losses.
Oct 5, 2026 — CMPS dips 2.5% to $11.60, a 1-month low, 5 down days in a row
- Closed at $11.60, -2.52% vs the prior close of $11.90. Day range $11.27–$12.06, opened at $12.00.
- Volume was 3.77M shares, 1.4x its 50-day average of 2.78M.
- Price is -13.2% vs its 50-day average ($13.37) and +16.5% vs its 200-day average ($9.96).
- 52-week range $4.88–$15.87; today's close sits at 61% of that range, 26.9% below the 52-week high.
- That makes 5 straight losses.
Oct 2, 2026 — CMPS dips 0.4% to $11.90, a 1-month low, 4 down days in a row
- Closed at $11.90, -0.42% vs the prior close of $11.95. Day range $11.63–$12.07, opened at $12.00.
- Volume was 2.66M shares, 1.0x its 50-day average of 2.76M.
- Price is -10.9% vs its 50-day average ($13.36) and +19.8% vs its 200-day average ($9.93).
- 52-week range $4.88–$15.87; today's close sits at 64% of that range, 25.0% below the 52-week high.
- That makes 4 straight losses.
CMPS latest news & SEC filings
Every SEC filing by or about CMPS in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Aug 10, 2026 · Form 144 — Planned insider sale
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Aug 7, 2026 · Form 144 — Planned insider sale
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Aug 5, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 5, 2026 · Form S-3ASR — S-3ASR filing
S-3ASR filing
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Aug 5, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Aug 5, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Net income: -$253.79M (prior year -$38.40M) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$1.88 (prior year -$0.41) (loss widened vs Jun 30, 2025)
Jul 7, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
- Item 8.01 — Reported other events the company considers important.
Things to know before you trade CMPS
- Last results release: Aug 5, 2026 (8-K Item 2.02). Previous ones: May 13, 2026, Mar 24, 2026, Nov 4, 2025. Based on that rhythm, the next report is likely around Nov 4, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 2.49% (largest 7.0%).
- Liquidity: about 2.72M shares (≈$31.59M) trade per day on average.
- 52-week position: $11.62 vs a range of $4.88–$15.87 (61% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 8-K Aug 5, 2026; 10-Q Aug 5, 2026; 8-K Jul 7, 2026.
- Share count: 138.48M shares outstanding (Jul 30, 2026), +44.3% vs a year earlier — notable dilution.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
CMPS market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 11.25 | 11.69 | 11.15 | 11.62 | 2.80M |
| Oct 14, 2026 | 11.09 | 11.50 | 10.97 | 11.27 | 2.53M |
| Oct 13, 2026 | 11.54 | 11.54 | 11.11 | 11.14 | 1.87M |
| Oct 12, 2026 | 12.02 | 12.05 | 11.53 | 11.53 | 1.96M |
| Oct 9, 2026 | 11.69 | 12.07 | 11.42 | 12.00 | 2.28M |
| Oct 8, 2026 | 11.69 | 11.79 | 11.13 | 11.47 | 2.83M |
| Oct 7, 2026 | 11.50 | 11.86 | 11.45 | 11.69 | 1.58M |
| Oct 6, 2026 | 11.72 | 11.80 | 11.17 | 11.56 | 2.80M |
| Oct 5, 2026 | 12.00 | 12.06 | 11.27 | 11.60 | 3.77M |
| Oct 2, 2026 | 12.00 | 12.07 | 11.63 | 11.90 | 2.66M |
| Oct 1, 2026 | 12.38 | 12.46 | 11.82 | 11.95 | 3.89M |
| Sep 30, 2026 | 13.11 | 13.15 | 12.42 | 12.44 | 3.05M |
| Sep 29, 2026 | 13.31 | 13.31 | 12.84 | 12.96 | 2.50M |
| Sep 28, 2026 | 13.10 | 13.49 | 12.82 | 13.23 | 1.78M |
| Sep 25, 2026 | 13.20 | 13.45 | 13.03 | 13.06 | 2.23M |
| Sep 24, 2026 | 13.60 | 13.77 | 12.95 | 13.09 | 3.91M |
| Sep 23, 2026 | 14.66 | 14.72 | 13.74 | 13.75 | 2.57M |
| Sep 22, 2026 | 15.13 | 15.35 | 14.56 | 14.78 | 2.31M |
| Sep 21, 2026 | 15.50 | 15.55 | 14.88 | 15.01 | 3.45M |
| Sep 18, 2026 | 15.10 | 15.43 | 14.76 | 15.19 | 3.57M |
About COMPASS Pathways
COMPASS Pathways (CMPS) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in CHESIRE, United Kingdom. State of incorporation: United Kingdom. Fiscal year ends December 31. SEC CIK 1816590.
CMPS board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Justin D. Gover | Director | May 29, 2026 |
| Jeffrey M Jonas | Director | May 29, 2026 |
| Daphne Karydas | Director | May 29, 2026 |
| Robert Mcquade | Director | May 29, 2026 |
| Kabir Nath | Chief Executive Officer | Aug 5, 2026 |
| David Y Norton | Director | May 29, 2026 |
| Wayne Joseph Riley | Director | May 29, 2026 |
| Gino Santini | Director | May 29, 2026 |
| Kathleen Tregoning | Director | May 29, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Guy Goodwin | Chief Medical Officer | Mar 27, 2026 |
| Teri Loxam | Chief Financial Officer | Mar 27, 2026 |
| Kabir Nath | Chief Executive Officer | Aug 5, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
CMPS financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | — | $-287.86M | -3.08 | $-157.24M |
| Dec 31, 2024 | — | $-155.12M | -2.30 | $-119.19M |
| Dec 31, 2023 | — | $-118.46M | -2.32 | $-97.38M |
| Dec 31, 2022 | — | $-91.50M | -2.16 | $-105.45M |
| Dec 31, 2021 | — | $-71.74M | -1.79 | $-67.75M |
Latest balance sheet: total assets $504.56M, total liabilities $420.03M, cash $433.30M (as of Jun 30, 2026).
CMPS earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 5, 2026 | 8-K Item 2.02 (results) | $13.58 |
| May 13, 2026 | 8-K Item 2.02 (results) | $10.96 |
| Mar 24, 2026 | 8-K Item 2.02 (results) | $5.22 |
| Nov 4, 2025 | 8-K Item 2.02 (results) | $6.63 |
| Jul 31, 2025 | 8-K Item 2.02 (results) | $4.35 |
| May 8, 2025 | 8-K Item 2.02 (results) | $3.76 |
| Feb 27, 2025 | 8-K Item 2.02 (results) | $3.92 |
| Oct 31, 2024 | 8-K Item 2.02 (results) | $4.76 |
| Aug 1, 2024 | 8-K Item 2.02 (results) | — |
| May 8, 2024 | 8-K Item 2.02 (results) | — |
| Feb 29, 2024 | 8-K Item 2.02 (results) | — |
| Nov 2, 2023 | 8-K Item 2.02 (results) | — |
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)AbbVie (ABBV)Merck (MRK)Abbott Laboratories (ABT)Vertex Pharmaceuticals Inc / Ma (VRTX)Pfizer (PFE)Bristol Myers Squibb (BMY)Astrazeneca (AZN)Regeneron Pharmaceuticals (REGN)
Popular today
Micron Technology (MU)Spdr S&P 500 Etf (SPY)Nvidia (NVDA)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Intel (INTC)Apple (AAPL)Microsoft (MSFT)Meta Platforms (META)Broadcom (AVGO)Tesla (TSLA)
More on CMPS
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.